- 全部删除
- 您的购物车当前为空
Strontium ranelate (S12911) 是抗骨质疏松的药物,能够抑制骨吸收,促进骨形成,进而促使正骨平衡。它还能够激活非骨骼细胞中的钙敏感受体 (CaSR),进而促进肌醇 1,4,5-三磷酸的生成及丝裂原活化的蛋白激酶信号转导。
为众多的药物研发团队赋能,
让新药发现更简单!
Strontium ranelate (S12911) 是抗骨质疏松的药物,能够抑制骨吸收,促进骨形成,进而促使正骨平衡。它还能够激活非骨骼细胞中的钙敏感受体 (CaSR),进而促进肌醇 1,4,5-三磷酸的生成及丝裂原活化的蛋白激酶信号转导。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 119 | In stock | |
5 mg | ¥ 176 | In stock | |
10 mg | ¥ 245 | In stock | |
25 mg | ¥ 388 | In stock | |
50 mg | ¥ 565 | In stock | |
100 mg | ¥ 828 | In stock | |
500 mg | ¥ 2,880 | In stock |
产品描述 | Strontium ranelate (S12911), a strontium (II) salt of the ranelic acid, is a medication for osteoporosis. Studies indicate it can also slow the course of osteoarthritis of the knee. The drug is unusual in that it both increases deposition of new bone by osteoblasts and reduces the resorption of bone by osteoclasts. It is therefore promoted as a "dual action bone agent" (DABA) indicated for use in the treatment of severe osteoporosis. |
靶点活性 | Ca2+ channel:0.5 mM |
别名 | 雷尼酸锶, S12911, Distrontium renelate |
分子量 | 513.49 |
分子式 | C12H6N2O8S·2Sr |
CAS No. | 135459-87-9 |
Smiles | [Sr+2].c1(c(c(c(s1)N(CC(=O)[O-])CC(=O)[O-])C#N)CC(=O)[O-])C(=O)[O-].[Sr+2] |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
溶解度信息 | DMSO: 5.13 mg/ml (10 mM), Sonication is recommended. ![]() H2O: Insoluble | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容